Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	3.36	47.30	45.76
Graham Fair Price	-8.33	21.26	23.19
PEG	83.02	-0.91	-5.36
Price/Book	-15.65	3.88	4.59
Price/Cash Flow	51.96	118.91	78.25
Prices/Earnings	9.38	17.38	15.89
Price/Sales	-4.60	16.90	17.72
Price/FCF	51.96	118.91	78.25
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-3.26	0.45	0.47
Operating Margin	-6.79	0.28	0.30
ROA	-21.09	0.03	0.04
ROE	0.07	0.06	-22.88
ROIC	0.05	0.04	-23.56
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	-0.03	-99.40
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.11	-0.14	-28.12
EPS QOQ	-0.03	-0.19	-544.08
FCF QOQ	2.42	-0.42	-82.63
Revenue QOQ	-0.07	-0.08	-3.21
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	176.60	189.13	7.09
Days Sales Outstanding (DSO)	41.72	42.20	1.15
Inventory Turnover	0.51	0.48	-6.62
Debt/Capitalization	0.30	0.29	-3.39
Quick Ratio	1.57	1.63	4.15
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	18.18	18.98	4.39
Cash	5.80	6.11	5.29
Capex	-0.36	-0.55	-51.69
Free Cash Flow	1.07	0.62	-42.06
Revenue	4.71	4.35	-7.70
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.71	2.87	6.17
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	1.10	1.09	-0.04
Naive Interpretation	Member

06 - Financial Health · Bad

Rating